Stay updated with breaking news from Balloon Sinus Dilation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The sinus dilation devices market size is estimated to grow by USD 1.50 billion from 2022 to 2027 at a CAGR of 8.54% according to Technavio....
/PRNewswire/ -- The "The US Drug Eluting Sinus Stent (DESS) Market: Analysis By Procedures (Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus...
The global sinus dilation device market size is estimated to reach USD 4.6 billion by 2028, registering a CAGR of 11.0%. In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation used in the treatment of recurrent acute sinusitis and chronic sinusitis.
Chronic sinusitis is a common condition where the cavities around the nasal passages (sinuses) become inflamed and swollen lasting for at least 12 weeks,...
Share this article Share this article ResearchAndMarkets.com's offering. The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician's office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some...